Nalu Medical
Venkat Gopal is an experienced finance and strategy professional currently serving as the Vice President of Strategy and Business Excellence at Nalu Medical, Inc. since December 2020, where focus is on miniature implantable devices for chronic pain treatment. Prior to this role, Venkat was the Associate Vice President of Finance, responsible for long-range financial planning and financing efforts, including IPO readiness. Venkat's previous experience includes serving as the Director of Financial Planning and Analysis at Vertiflex, which was acquired by Boston Scientific, and holding the position of Global Finance Director at Genentech. Earlier career includes roles at Abbott in finance and supply chain management. Venkat holds an MBA in Finance and Corporate Strategy and an MS in Operations Management & Manufacturing Engineering from the University of Michigan, along with a BS in Manufacturing Engineering from PSG College of Technology.
This person is not in any teams
Nalu Medical
Nalu Medical, Inc. is a privately held commercial medical device company based in Carlsbad, California. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The system is highly capable and easily upgradeable, providing a menu of therapy options.